.   
  
. 
   Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women.  
  Herbst AL, Ulfelder H, Poskanzer DC. Herbst AL, et al.
.   
  
. 
  
. 
   Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.  
			
			
			- Gluten intolerance a significant risk factor
 - Infectious disease of the uterus
 - Absence of an individual specific disease